Results 171 to 180 of about 45,124 (242)

Teduglutide in pediatric patients under 10 kg with short bowel syndrome on parenteral support: An open‐label study

open access: yesPediatrics International, Volume 68, Issue 1, January/December 2026.
Abstract Background Patients with short bowel syndrome (SBS)‐associated intestinal failure (SBS‐IF) are dependent on parenteral support (PS). In Japan, teduglutide is the only GLP‐2 analog medicine indicated for these patients. There are limited data for pediatric patients, especially those with a low body weight.
Kouji Masumoto   +9 more
wiley   +1 more source

The role of abdominal ultrasound in surgical decision making for necrotizing enterocolitis. [PDF]

open access: yesJ Neonatal Perinatal Med
Garg PM   +4 more
europepmc   +1 more source

Intestinal and Multivisceral Transplantation: Where We Stand Today

open access: yesPediatric Transplantation, Volume 30, Issue 1, January 2026.
ABSTRACT Intestinal and multivisceral transplantation has evolved from an experimental to a life‐saving procedure for children and adults with complications of gut failure (GF). Suboptimal long‐term outcomes of transplant elicit recent advances in surgical and medical gut rehabilitation along with the introduction of glucagon‐like peptide‐2 (GLP‐2 ...
Mohamed Maklad   +5 more
wiley   +1 more source

Elevated DUOX2 levels correlate with necrotizing enterocolitis development. [PDF]

open access: yesFront Cell Infect Microbiol
Sun W   +7 more
europepmc   +1 more source

An Interventional Study on the Late Treatment of Severe Bronchopulmonary Dysplasia in Preterm Infants Using Mesenchymal Stromal Cells

open access: yesStem Cells International, Volume 2026, Issue 1, 2026.
Background Bronchopulmonary dysplasia (BPD) remains a significant challenge in the management of preterm infants. Although conventional treatment approaches have helped reduce the morbidity associated with BPD, the prevalence of the condition has not decreased, highlighting an urgent need for new therapies.
Sukran Yildirim, Ludovic Zimmerlin
wiley   +1 more source

Update of the list of qualified presumption of safety (QPS) recommended microbiological agents intentionally added to food or feed as notified to EFSA 23: Suitability of taxonomic units notified to EFSA until September 2025

open access: yesEFSA Journal, Volume 24, Issue 1, January 2026.
Abstract The qualified presumption of safety (QPS) process was developed to provide a harmonised safety assessment approach to support EFSA Scientific Panels and Units. The QPS approach assesses the taxonomic identity, body of relevant knowledge and safety of microorganisms intentionally added to the food and feed chain.
EFSA Panel on Biological Hazards (BIOHAZ)   +28 more
wiley   +1 more source

Home - About - Disclaimer - Privacy